CFTR and cystic fibrosis: We also provide evidence that ASO-induced exon 23 skipping has partial allele specificity for CFTR-W1282X, which could be advantageous in treating CF patients heterozygous for CFTR-W1282X and another mutation less responsive to current therapeutics.